# A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

> **NCT06088017** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 66 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **DRUG:** CKD-391(2)
- **DRUG:** CKD-331, D337

## Key facts

- **NCT ID:** NCT06088017
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-23
- **Primary completion:** 2024-01-07
- **Final completion:** 2024-01-22
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06088017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06088017, "A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06088017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*